Literature DB >> 27650074

δ-Aminolevulinate Dehydratase Activity is Stimulated in a MPTP Mouse Model of Parkinson's Disease: Correlation with Myeloperoxidase Activity.

Tuane Bazanella Sampaio1, Marcel Henrique Marcondes Sari1, Ana Paula Pesarico1, Cristina Wayne Nogueira2.   

Abstract

Myeloperoxidase (MPO) is an inducible heme peroxidase responsive to some stress situations. It is already known that its activity is stimulated in neurodegenerative disorders and in the animal model of parkinson's disease (PD) induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). By contrast, the role of δ-aminolevulinate dehydratase (δ-ALA-D), an essential enzyme for heme synthesis, has not been investigated in the MPTP model. The aim of this study was to investigate the involvement of striatal δ-ALA-D activity in an acute model of PD, induced by MPTP, in C57Bl/6 mice and its correlation with MPO activity. Animals received four MPTP injections (20 mg/kg, i.p.) or saline (vehicle) to induce a PD model. 7 days after MPTP administration, the motor function was evaluated through rotarod and challenging beam tests in mice. Afterward, mice were killed, and the striata were removed for biochemical analyses. MPTP-treated mice showed impairment in motor skills, such as balance and motor coordination. Furthermore, there was a reduction of tyrosine hydroxylase levels in these animals, which characterizes the dopaminergic lesion. Striatal δ-ALA-D activity was stimulated by MPTP, as well as the MPO activity, and a significant positive correlation between δ-ALA-D and MPO activities was also demonstrated. These data suggest that δ-ALA-D activity could be stimulated due to the requirement of heme groups by peroxidases. Therefore, this study demonstrated for the first time the involvement of striatal δ-ALA-D activity in the MPTP model and its correlation with the MPO activity.

Entities:  

Keywords:  Heme; MPTP; Myeloperoxidase; Parkinson’s disease; Peroxidase; δ-ALA-D

Mesh:

Substances:

Year:  2016        PMID: 27650074     DOI: 10.1007/s10571-016-0428-2

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  44 in total

1.  Ethyl pyruvate rescues nigrostriatal dopaminergic neurons by regulating glial activation in a mouse model of Parkinson's disease.

Authors:  Sue H Huh; Young C Chung; Ying Piao; Min Y Jin; Hyo J Son; Nam S Yoon; Joo Y Hong; Youngmi K Pak; Yoon S Kim; Jong K Hong; Onyou Hwang; Byung K Jin
Journal:  J Immunol       Date:  2011-06-17       Impact factor: 5.422

Review 2.  Novel pharmacological targets for the treatment of Parkinson's disease.

Authors:  Anthony H V Schapira; Erwan Bezard; Jonathan Brotchie; Frédéric Calon; Graham L Collingridge; Borris Ferger; Bastian Hengerer; Etienne Hirsch; Peter Jenner; Nicolas Le Novère; José A Obeso; Michael A Schwarzschild; Umberto Spampinato; Giora Davidai
Journal:  Nat Rev Drug Discov       Date:  2006-10       Impact factor: 84.694

Review 3.  Peroxidases: a role in the metabolism and side effects of drugs.

Authors:  Shahrzad Tafazoli; Peter J O'Brien
Journal:  Drug Discov Today       Date:  2005-05-01       Impact factor: 7.851

4.  Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein.

Authors:  Sheila M Fleming; Jonathan Salcedo; Pierre-Olivier Fernagut; Edward Rockenstein; Eliezer Masliah; Michael S Levine; Marie-Françoise Chesselet
Journal:  J Neurosci       Date:  2004-10-20       Impact factor: 6.167

5.  The cytotoxic activity of lactoperoxidase: enhancement and inhibition by neuroactive compounds.

Authors:  Johannes Everse; Penelope W Coates
Journal:  Free Radic Biol Med       Date:  2004-09-15       Impact factor: 7.376

Review 6.  Tyrosine hydroxylase and Parkinson's disease.

Authors:  J Haavik; K Toska
Journal:  Mol Neurobiol       Date:  1998-06       Impact factor: 5.590

7.  Role of myeloperoxidase in luminol-dependent chemiluminescence of polymorphonuclear leukocytes.

Authors:  C Dahlgren; O Stendahl
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

8.  Long-term retention of neurotoxic beta-carbolines in brain neuromelanin.

Authors:  A Ostergren; A Annas; K Skog; N G Lindquist; E B Brittebo
Journal:  J Neural Transm (Vienna)       Date:  2003-12-03       Impact factor: 3.575

9.  The influence of the serum vitamin C levels on oxidative stress biomarkers in elderly women.

Authors:  Clóvis Paniz; André Bairros; Juliana Valentini; Mariele Charão; Rachel Bulcão; Angela Moro; Tilman Grune; Solange Cristina Garcia
Journal:  Clin Biochem       Date:  2007-08-29       Impact factor: 3.281

10.  Measuring myeloperoxidase activity in biological samples.

Authors:  Benjamin Pulli; Muhammad Ali; Reza Forghani; Stefan Schob; Kevin L C Hsieh; Gregory Wojtkiewicz; Jenny J Linnoila; John W Chen
Journal:  PLoS One       Date:  2013-07-05       Impact factor: 3.240

View more
  2 in total

Review 1.  Mitochondrial Targeting in Neurodegeneration: A Heme Perspective.

Authors:  Veronica Fiorito; Deborah Chiabrando; Emanuela Tolosano
Journal:  Pharmaceuticals (Basel)       Date:  2018-09-18

Review 2.  Unraveling the Role of Heme in Neurodegeneration.

Authors:  Deborah Chiabrando; Veronica Fiorito; Sara Petrillo; Emanuela Tolosano
Journal:  Front Neurosci       Date:  2018-10-09       Impact factor: 4.677

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.